Share
Export Citation
Survival of lung cancer patients in Dr Wahidin Sudirohusodo Hospital Makassar 2012-2016
Annah I.
ACM International Conference Proceeding Series
Abstract
This study aimed to found out the proportion of the determinant of survival in lung cancer patients who come for treatment in the DR Wahidin Sudirohusodo Hospital Makassar period 2012-2016. The study was conducted at Dr. Wahidin Sudirohusodo Hospital Makassar. The study design was observational analytic with Retrospective Cohort. Sampling was done by exhaustive sampling method with total sample of 144 patients who diagnosed with lung cancer and recorded in the medical records of DR Wahidin Sudirohusodo Hospital period 2012-2016. The results of the study reveals that a 1-year survival rate of lung cancer patients was 24%, 2-year survival rate was 16%, and 3-year survival rate was 14%. The survival proportion of lung cancer with a BMI <18,5 was 6% and BMI ≥ 18,5 was 50% with HR 3,163 (95% CI = 1,802--5,551); severe comorbidities was 7% and mild comorbidities was 20% with HR 1,599 (95% CI = 1,110--2,302); advanced stage was 2% and early stage was 60% with HR 12,635 (95% CI = 6,222--25,660); bad performance status was 11% and good performance status was 21% with HR 1,987(95% CI = 1,335--2,960); and patients who underwent palliative treatment was 5% and patients who underwent curative treatment was 27% with HR 3,177 (95% CI = 2,123--4,754). Multivariate analysis showed that the most associated factors with survival of patients with lung cancer is stage (HR = 10,010; 95% CI=4,851--21,893), the type of treatment (HR = 1,659; 95% CI=1,095--2,514) and the interaction between gender and performance status (HR = 1,472; 95% CI=1,014--2,136).